Written by Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. […]
Tuberculosis is a chronic disease that has been around for centuries, yet why they persist in the human body is not fully understood. Some patients now are donating lung tissue for use in TB research. Spotlight explores why these samples are so important to unlocking the mysteries of what the TB bacterium does inside the […]
.Merck & Co.’s long-running initiative to land a strike on little cell lung cancer (SCLC) has acquired a small triumph. The drugmaker’s Daiichi Sankyo-partnered antibody-drug conjugate (ADC) ifinatamab deruxtecan (I-DXd) revealed potential in the setting, providing motivation as a late-stage test advances.SCLC is one of the growth styles where Merck’s Keytruda fell short, leading the […]